1: Wang X, Wedge DE, Cutler SJ. Chemical and Biological Study of Cladosporin, an Antimicrobial Inhibitor: A Review. Nat Prod Commun. 2016 Oct;11(10):1595-1600. PMID: 30549627.
2: Fredenhagen A, Schroer K, Schröder H, Hoepfner D, Ligibel M, Porchet Zemp L, Radoch C, Freund E, Meishammer A. Cladosporin Derivatives Obtained by Biotransformation Provide Guidance for the Focused Derivatization of this Antimalarial Lead Compound. Chembiochem. 2019 Mar 1;20(5):650-654. doi: 10.1002/cbic.201800588. Epub 2018 Dec 11. PMID: 30347507.
3: Rusch M, Thevenon A, Hoepfner D, Aust T, Studer C, Patoor M, Rollin P, Livendahl M, Ranieri B, Schmitt E, Spanka C, Gademann K, Bouchez LC. Design and Synthesis of Metabolically Stable tRNA Synthetase Inhibitors Derived from Cladosporin. Chembiochem. 2019 Mar 1;20(5):644-649. doi: 10.1002/cbic.201800587. Epub 2019 Feb 4. PMID: 30462880.
4: Cochrane RV, Sanichar R, Lambkin GR, Reiz B, Xu W, Tang Y, Vederas JC. Production of New Cladosporin Analogues by Reconstitution of the Polyketide Synthases Responsible for the Biosynthesis of this Antimalarial Agent. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):664-8. doi: 10.1002/anie.201509345. Epub 2015 Nov 24. PMID: 26783060; PMCID: PMC4906947.
5: Baragaña B, Forte B, Choi R, Nakazawa Hewitt S, Bueren-Calabuig JA, Pisco JP, Peet C, Dranow DM, Robinson DA, Jansen C, Norcross NR, Vinayak S, Anderson M, Brooks CF, Cooper CA, Damerow S, Delves M, Dowers K, Duffy J, Edwards TE, Hallyburton I, Horst BG, Hulverson MA, Ferguson L, Jiménez-Díaz MB, Jumani RS, Lorimer DD, Love MS, Maher S, Matthews H, McNamara CW, Miller P, O'Neill S, Ojo KK, Osuna-Cabello M, Pinto E, Post J, Riley J, Rottmann M, Sanz LM, Scullion P, Sharma A, Shepherd SM, Shishikura Y, Simeons FRC, Stebbins EE, Stojanovski L, Straschil U, Tamaki FK, Tamjar J, Torrie LS, Vantaux A, Witkowski B, Wittlin S, Yogavel M, Zuccotto F, Angulo-Barturen I, Sinden R, Baum J, Gamo FJ, Mäser P, Kyle DE, Winzeler EA, Myler PJ, Wyatt PG, Floyd D, Matthews D, Sharma A, Striepen B, Huston CD, Gray DW, Fairlamb AH, Pisliakov AV, Walpole C, Read KD, Van Voorhis WC, Gilbert IH. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7015-7020. doi: 10.1073/pnas.1814685116. Epub 2019 Mar 20. PMID: 30894487; PMCID: PMC6452685.
6: Das P, Babbar P, Malhotra N, Sharma M, Jachak GR, Gonnade RG, Shanmugam D, Harlos K, Yogavel M, Sharma A, Reddy DS. Specific Stereoisomeric Conformations Determine the Drug Potency of Cladosporin Scaffold against Malarial Parasite. J Med Chem. 2018 Jul 12;61(13):5664-5678. doi: 10.1021/acs.jmedchem.8b00565. Epub 2018 Jun 4. PMID: 29779382.
7: Khan S, Sharma A, Belrhali H, Yogavel M, Sharma A. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin. J Struct Funct Genomics. 2014 Jun;15(2):63-71. doi: 10.1007/s10969-014-9182-1. Epub 2014 Jun 17. PMID: 24935905.
8: Chhibber-Goel J, Sharma A. Side chain rotameric changes and backbone dynamics enable specific cladosporin binding in Plasmodium falciparum lysyl-tRNA synthetase. Proteins. 2019 Sep;87(9):730-737. doi: 10.1002/prot.25699. Epub 2019 May 9. PMID: 31017332.
9: Zheng H, Zhao C, Fang B, Jing P, Yang J, Xie X, She X. Asymmetric total synthesis of cladosporin and isocladosporin. J Org Chem. 2012 Jul 6;77(13):5656-63. doi: 10.1021/jo300805n. Epub 2012 Jun 11. PMID: 22663064.
10: Scott PM, Van Walbeek W, MacLean WM. Cladosporin, a new antifungal metabolite from Cladosporium cladosporioides. J Antibiot (Tokyo). 1971 Nov;24(11):747-55. doi: 10.7164/antibiotics.24.747. PMID: 5169000.